Announcements & News Releases

Date Title of Press Release
06/27/2011 Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc.
06/21/2011 Luminex Corporation Announces Agreement to Acquire EraGen Biosciences, Inc. Acquisition Expands Molecular Diagnostic and Infectious Disease Capabilities
05/04/2011 EraGen to Host Corporate Workshop at 2011 Clinical Virology Symposium
04/19/2011 Applied BioCode announces strategic technology partnership, license agreement with EraGen Biosciences
01/11/2011 EraGen Appoints Gregory D. Rodgers Vice President of Manufacturing
12/02/2010 EraGen to support manufacturing expansion with federal grant
07/27/2010 EraGen Appoints Industry Veteran Dunn Vice President of Quality, Regulatory and Clinical Affairs
07/12/2010 EraGen announces completion of major sales, support organization expansion
05/28/2010 EraGen Biosciences Announces FDA Clearance of First Herpes Simplex Virus PCR Test For Vaginal Lesion Swabs
11/18/2009 EraGen Announces a Strategic Partnership, Licensing Agreement with Illumina
09/22/2008 EraGen Receives Health Canada Approval of Five MultiCode-RTx Molecular Diagnostic Tests
04/10/2006 EraGen Biosciences Establishing Strategic Alliances within Wisconsin to Address Global Health Concerns
01/30/2006 EraGen Biosciences Announces Greg R. Johnson, Managing Director, Prolog Ventures, Dr. Tracy Marshbanks, Vice President, First Analysis and Bruce D. Neviaser, General Partner, Continuum Investment, LP, Join Board of Directors
01/09/2006 EraGen Biosciences Closes on $12 Million in Series A Financing
05/24/2005 Gov. Doyle Announces Funding for Further Expansion of EraGen Biosciences, Inc. Product Development Capabilities
05/18/2005 EraGen Biosciences and Bayer HealthCare LLC, Diagnostics Division, Announce Agreements for New Cystic Fibrosis (CF) Assay
02/04/2005 President of EraGen Biosciences and the Wisconsin Biotechnology & Medical Device Association (WBMA) to Speak at Women in Health Care Management (WHCM) Dinner
  • #
  • #
  • #